QC
Quadrature Capital Portfolio holdings
AUM
$5.81B
1-Year Return
34.32%
This Quarter Return
+21.57%
1 Year Return
+34.32%
3 Year Return
+92.3%
5 Year Return
+128.17%
10 Year Return
+279.79%
AUM
$5.81B
AUM Growth
+$1.3B
(+29%)
Cap. Flow
+$827M
Cap. Flow
% of AUM
14.25%
Top 10 Holdings %
Top 10 Hldgs %
27.87%
Holding
1,608
New
576
Increased
221
Reduced
201
Closed
609
Top Buys
| 1 |
NVIDIA
NVDA
|
+$339M |
| 2 |
Apple
AAPL
|
+$306M |
| 3 |
UnitedHealth
UNH
|
+$175M |
| 4 |
Microsoft
MSFT
|
+$153M |
| 5 |
Netflix
NFLX
|
+$120M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
+$219M |
| 2 |
Broadcom
AVGO
|
+$213M |
| 3 |
Canadian Natural Resources
CNQ
|
+$113M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
+$99.2M |
| 5 |
Toronto Dominion Bank
TD
|
+$86.3M |
Sector Composition
| 1 | Technology | 28.21% |
| 2 | Financials | 14.38% |
| 3 | Healthcare | 10.22% |
| 4 | Communication Services | 7.09% |
| 5 | Consumer Discretionary | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAK
926
Northern Dynasty Minerals
NAK
$450M
| $62.5K | ﹤0.01% |
46,294
-232,006
| -83% | -$313K |
|
927
HilleVax
HLVX
$105M
| $61.6K | ﹤0.01% |
+30,942
| New | +$61.6K |
|
|
EPRX
928
Eupraxia Pharmaceuticals
EPRX
$197M
| $61.4K | ﹤0.01% |
+10,700
| New | +$61.4K |
|
|
BZUN
929
Baozun
BZUN
$258M
| $61.1K | ﹤0.01% |
+24,323
| New | +$61.1K |
|
930
Unisys
UIS
$291M
| $60.8K | ﹤0.01% |
+13,419
| New | +$60.8K |
|
931
Zentalis Pharmaceuticals
ZNTL
$113M
| $60.6K | ﹤0.01% |
+52,456
| New | +$60.6K |
|
932
MaxCyte
MXCT
$158M
| $60.4K | ﹤0.01% |
+27,760
| New | +$60.4K |
|
933
Riskified
RSKD
$732M
| $60.3K | ﹤0.01% |
12,097
-14,309
| -54% | -$71.3K |
|
934
FerroAtlántica
GSM
$795M
| $59.3K | ﹤0.01% |
16,205
-5,129
| -24% | -$18.8K |
|
935
8x8 Inc
EGHT
$303M
| $57.3K | ﹤0.01% |
+29,209
| New | +$57.3K |
|
936
One Stop Systems
OSS
$122M
| $57K | ﹤0.01% |
+16,025
| New | +$57K |
|
937
Gran Tierra Energy
GTE
$139M
| $56.4K | ﹤0.01% |
+11,831
| New | +$56.4K |
|
938
Avalo Therapeutics
AVTX
$143M
| $54.8K | ﹤0.01% |
+10,976
| New | +$54.8K |
|
939
Aclaris Therapeutics
ACRS
$213M
| $54.5K | ﹤0.01% |
38,250
-1,081
| -3% | -$1.54K |
|
940
Playboy, Inc. Common Stock
PLBY
$188M
| $54.2K | ﹤0.01% |
+33,656
| New | +$54.2K |
|
|
DDL
941
Dingdong
DDL
$492M
| $53.7K | ﹤0.01% |
26,583
-2,489
| -9% | -$5.03K |
|
942
SELLAS Life Sciences
SLS
$199M
| $52.7K | ﹤0.01% |
24,284
+3,611
| +17% | +$7.84K |
|
|
NXDR
943
Nextdoor Holdings
NXDR
$794M
| $52.4K | ﹤0.01% |
31,688
-23,635
| -43% | -$39.1K |
|
944
Rayonier Advanced Materials
RYAM
$411M
| $52K | ﹤0.01% |
+13,532
| New | +$52K |
|
|
ONL
945
Orion Office REIT
ONL
$166M
| $50.3K | ﹤0.01% |
+23,500
| New | +$50.3K |
|
946
Allogene Therapeutics
ALLO
$260M
| $50K | ﹤0.01% |
44,050
+10,059
| +30% | +$11.4K |
|
947
Ostin Technology Group
OST
$9.11M
| $49.2K | ﹤0.01% |
+12,724
| New | +$49.2K |
|
948
Annexon
ANNX
$280M
| $49.1K | ﹤0.01% |
20,515
+2,783
| +16% | +$6.67K |
|
949
Dakota Gold
DC
$547M
| $49K | ﹤0.01% |
13,285
-1,911
| -13% | -$7.05K |
|
950
PLAYSTUDIOS Inc
MYPS
$120M
| $48.5K | ﹤0.01% |
+37,331
| New | +$48.5K |
|